Emcure Pharmaceuticals Ltd Free Cash Flow Generation Index
Emcure Pharmaceuticals Ltd free cash flow generation index. Emcure Pharmaceuticals Ltd (EMCURE) has a Free Cash Flow Generation Index of 0.50x as of September 2025. Free cash flow of Rs1.27 Billion represents 0% of operating cash flow (Rs2.56 Billion). Check Emcure Pharmaceuticals Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Emcure Pharmaceuticals Ltd (2022–2026)
Free cash flow generation index of Emcure Pharmaceuticals Ltd from 2022 to 2026. Historical FCF Generation Index trend for Emcure Pharmaceuticals Ltd across 5 annual periods. Explore capital reinvestment ratio of Emcure Pharmaceuticals Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Emcure Pharmaceuticals Ltd Free Cash Flow Generation Index by Year (2022–2026)
Emcure Pharmaceuticals Ltd free cash flow generation index by year from 2022 to 2026. Year-by-year Free Cash Flow Generation Index for Emcure Pharmaceuticals Ltd. For the full cash flow conversion analysis, see EMCURE cash generation efficiency.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.58x | Rs4.90 Billion | Rs8.51 Billion | Rs3.61 Billion | ▲ +10.3% |
| 2025 | 0.52x | Rs4.45 Billion | Rs8.52 Billion | Rs4.07 Billion | ▼ -27.5% |
| 2024 | 0.72x | Rs7.90 Billion | Rs10.97 Billion | Rs3.07 Billion | ▲ +56.6% |
| 2023 | 0.46x | Rs3.43 Billion | Rs7.47 Billion | Rs4.03 Billion | ▼ -4.8% |
| 2022 | 0.48x | Rs3.71 Billion | Rs7.68 Billion | Rs3.97 Billion | — |